Senior Director, Investor Relations

Parabilis Medicines · Cambridge, MA · 1 wk ago

On-siteMarketing$255k–$295k/yrFull-time

About Parabilis Medicines

At Parabilis Medicines, we are redefining what's possible in drug discovery. We are a clinical-stage biopharmaceutical company dedicated to creating unique and extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered beyond the reach of conventional medicines. Our proprietary Helicon™ platform has pioneered a new class of stabilized alpha-helical peptides capable of modulating intracellular proteins that have historically been considered "undruggable." Our lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin interaction that has demonstrated compelling early clinical activity across a range of Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP), adamantinomatous craniopharyngioma (ACP), hepatocellular carcinoma (HCC) and other solid tumor indications. We are also advancing a growing pipeline of additional medicines including franchise-extended beta catenin degraders, and Helicon peptides targeting prostate cancer and a range of other cancers.

Our mission is clear: transform the lives of more patients, and their families and communities. As a member of the Parabilis team, you'll work alongside scientists, clinicians, and innovators who are driven by curiosity, collaboration, and a shared commitment to tackling some of the most difficult challenges in medicine.

About the Role

The Head of Investor Relations is responsible for developing and implementing the IR strategy and operations for Parabilis Medicines. This role will develop and maintain the investor community and serve as the primary company contact for current and potential investors. The Head of IR will partner with the CEO and CFO to enhance and drive forward a strategic IR plan, conveying Parabilis' story and value proposition to both sell-side and buy-side investors with the goal of expanding the investor base.

Responsibilities

Partner with the CEO and CFO to enhance and drive forward a strategic IR plan and strategy to effectively convey Parabilis' story and value proposition to both the sell-side and buy-side with a goal of expanding the investor base.
Work closely with the CBSO and Corporate Communications to adapt the broader corporate narrative and messaging to current and potential investors.
Create a strategy and tactical plan to continuously deepen interest from current and target investors, and develop a multi-year plan to evolve this investor base alongside company growth.
Lead and manage Parabilis' participation in quarterly earnings calls, investment conference calls, in-house meetings, road shows, analyst days, and one-on-one meetings.
Develop relationships and maintain regular communication with individual investors and select buy-side and sell-side contacts to provide up-to-date information about events and market trends affecting Parabilis.
Ensure the development of supporting documents, such as analyst consensus models, investor analytics, company valuation spreadsheets, investor presentations, quarterly earnings scripts, Q&A for senior management, and press releases related to the financial community.
Support Finance and Legal in developing finance-related investor communications and filings (e.g., quarterly earnings calls, 10-K).
Serve as the primary contact for incoming inquiries from the media and investors; record and summarize all investor and analyst contact.
Proactively engage investors and sell-side analysts to articulate the strategy and status of Parabilis' progress.
Work productively with the Executive Team to understand the timing and impact of business events.
Develop a thorough understanding of Parabilis' pipeline and corporate strategy to support the delivery of milestones and inflection points clearly, compellingly, and compliantly to internal and external audiences.
Create a targeting strategy for prospective investors; establish close relationships with key investors and analysts.
Keep abreast of industry trends and competitive landscape to adjust plans, messaging, and manage relationships proactively and reactively.
Monitor Wall Street analysts' models and estimates; compile and communicate quarterly consensus for internal and external stakeholders.
Set the plan to execute investor conferences and events.
Collaborate with Corporate Communications to originate and maintain investor-facing materials, including financial results press releases, investor presentations, conference call scripts, Q&As, IR website, and backgrounders.

Qualifications

Bachelor of Arts or Bachelor of Science degree required; advanced degree a plus.
Minimum 12+ years' experience with a focus on investor relations, finance, equity research, or investment banking; public company experience required. Biotech experience preferred.
Strong knowledge of the strategy and individual investors appropriate for Parabilis' evolving story, ideally with familiarity in both US and ex-US investors.
A proactive, strategic approach to investor relations and communications.
Ability to relay deep science to external stakeholders and a strong understanding of general science and drug development.
Existing relationships within the financial, industry analyst, media, and institutional investor communities.
Outstanding oral and written communications and presentation skills.
Strong analytical skills, proficient with modern tools.
Proven ability to plan, organize, and execute IR-related events.
Ability to collaborate effectively with executives and senior leaders; able to work collaboratively across functions.
Demonstrated ability to develop, establish, and maintain relationships with healthcare investors and research analysts.
Ability to travel up to 20%.

Core Values

Growth-Minded: We're inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about but always considered impossible to drug. Our work requires us to be curious, humble, and adaptable.
In(ter)dependent: We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
Patient-focused: We are deeply focused on patient outcomes, and all energy in the company is directed toward science as it translates to patient impact.
All-In: We're All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

Pay

The base salary target for this position is $255,000–$295,000 per year, depending on experience, qualifications, and internal practices. Parabilis's total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support employees' overall well-being.